Drug class
Technetium-99m exametazime (HMPAO); diagnostic radiopharmaceutical tracer
Mechanism of action
Lipophilic 99mTc-labelled complex crosses cell membranes and is retained intracellularly after conversion to a more hydrophilic form. Distribution reflects regional perfusion or labelled leukocyte localisation, depending on the prepared product.
General use cases
- Diagnostic SPECT imaging of regional cerebral perfusion using 99mTc-exametazime prepared for brain imaging
- In-vitro radiolabelling of autologous leukocytes with 99mTc-exametazime for imaging suspected infection or inflammation; these are distinct preparation and use pathways
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
